Effects of Nonpeptide V1 Vasopressin Receptor Antagonist SR-49059 on Infarction Volume and Recovery of Function in a Focal Embolic Stroke Model

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Stroke

• Publication date

  2002-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/01.STR.0000039405.31526.06PMID 12468809
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Glycoprotein IIb/IIIa Antagonist, Murine 7E3 F(ab′)2, and Tissue Plasminogen Activator in Focal Ischemia: Evaluation of Efficacy and Risk of Hemorrhage with Combination Therapy

  2002cited by this paper
• Human Albumin Therapy of Acute Ischemic Stroke: Marked Neuroprotective Efficacy at Moderate Doses and With a Broad Therapeutic Window

  2001cited by this paper
• Protective Effect of Endothelin Type A Receptor Antagonist on Brain Edema and Injury After Transient Middle Cerebral Artery Occlusion in Rats

  2001cited by this paper
• Effective plasma concentration of a novel Na+/Ca2+ channel blocker NS-7 for its cerebroprotective actions in rats with a transient middle cerebral artery occlusion.

  2001cited by this paper
• An improved version of embolic model of brain ischemic injury in the rat.

  2001cited by this paper
• A focal embolic model of cerebral ischemia in rats: introduction and evaluation.

  2001cited by this paper
• Patency of Cerebral Microvessels after Focal Embolic Stroke in the Rat

  2001cited by this paper
• Depletion of circulating alpha(2)-antiplasmin by intravenous plasmin or immunoneutralization reduces focal cerebral ischemic injury in the absence of arterial recanalization.

  2001cited by this paper
• Usefulness of postischemic thrombolysis with or without neuroprotection in a focal embolic model of cerebral ischemia.

  2000cited by this paper
• Dose‐dependent neuroprotection with tiagabine in a focal cerebral ischemia model in rat

  2000cited by this paper
• Treatment of Brain Edema with a Nonpeptide Arginine Vasopressin V1 Receptor Antagonist OPC-21268 in Rats

  1999cited by this paper
• Binding of the Non-Peptide Vasopressin V1a Receptor Antagonist SR-49059 in the Rat Brain: An in vitro and in vivo Autoradiographic Study

  1999cited by this paper
• Effects of MDL 72527, a Specific Inhibitor of Polyamine Oxidase, on Brain Edema, Ischemic Injury Volume, and Tissue Polyamine Levels in Rats After Temporary Middle Cerebral After Occlusion

  1999cited by this paper
• Treatment of brain edema with a nonpeptide arginine vasopressin V1 receptor antagonist OPC-21268 in rats.

  1999cited by this paper
• Prevention of both T2- and diffusion-weighted increases in image intensity during cerebral hypoxia-ischemia in infant rats pretreated with dexamethasone

  1999cited by this paper
• Effects of the nonpeptide V(1) vasopressin receptor antagonist SR49059 in hypertensive patients.

  1999cited by this paper
• Quantification of infarct size on focal cerebral ischemia model of rats using a simple and economical method.

  1998cited by this paper
• Multiple-dose mannitol reduces brain water content in a rat model of cortical infarction.

  1997cited by this paper
• Interleukin-1 as a pathogenetic mediator of ischemic brain damage in rats.

  1995cited by this paper
• Biochemical and pharmacological properties of SR 49059, a new, potent, nonpeptide antagonist of rat and human vasopressin V1a receptors.

  1993cited by this paper
• A role for centrally-released vasopressin in brain ion and volume regulation: a hypothesis.

  1992cited by this paper
• Attenuated Development of Ischemic Brain Edema in Vasopressin-Deficient Rats

  1992cited by this paper
• Brain edema and cerebrovascular permeability during cerebral ischemia in rats.

  1990cited by this paper
• Arginine vasopressin receptors in pig cerebral microvessels, cerebral cortex and hippocampus.

  1988cited by this paper
• Humoral Regulation of Blood Flow to Choroid Plexus: Role of Arginine Vasopressin

  1988cited by this paper
• Vasopressin Localization and Putative Functions in the Brain

  1987cited by this paper
• Vasopressin

  1987cited by this paper
• Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination.

  1986cited by this paper
• Cortical Tissue Pressure Gradients in Early Ischemic Brain Edema

  1986cited by this paper
• Brain tissue pressure in focal cerebral ischemia.

  1985cited by this paper
• Involvement of vasopressin in brain edema formation: further evidence obtained from the Brattleboro diabetes insipidus rat with experimental subarachnoid hemorrhage.

  1984cited by this paper
• Experimental Brain Infarcts in Cats: II. Ischemic Brain Edema

  1980cited by this paper
• Regulation of brain water permeability by centrally-released vasopressin.

  1978cited by this paper
• Brain edema.

  1975cited by this paper
• Circulatory and metabolic effects of glycerol infusion in patients with recent cerebral infarction.

  1975cited by this paper
• The Effect of Dexamethasone on the Edema of Focal Cerebral Ischemia

  1973cited by this paper
• Modification of seizure activity by electrical stimulation. II. Motor seizure.

  1972cited by this paper
• Effect of Dexamethasone on the Early Edema Following Occlusion of the Middle Cerebral Artery in Cats

  1972cited by this paper
• Effect of Intravenous Infusion of Glycerol on Hemispheric Blood Flow and Metabolism in Patients With Acute Cerebral Infarction

  1972cited by this paper
• Treatment with glycerol of cerebral oedema due to acute cerebral infarction.

  1971cited by this paper
• Abnormal histidine metabolism in thyrotoxicosis in man. A possible index of impaired folate function.

  1965cited by this paper

• The neuropeptide in ischemic brain injury: insights, challenges, and horizon of targeted interventions.

  2026cites this paper
• Young rat vascular endothelial cells promote neurological recovery of stroke aged rat via HIF-1α

  2025cites this paper
• Relcovaptan: a promising therapeutic agent in traumatic spinal cord injury that acts by modulating newly identified transcriptional regulators of aquaporins compared to tolvaptan

  2025cites this paper
• Benserazide is neuroprotective and improves functional recovery after experimental ischemic stroke by altering the immune response

  2024cites this paper
• Significance of Neurotransmitters in Cerebral Ischemia: Understanding the Role of Serotonin, Dopamine, Glutamate, and GABA in Stroke Recovery and Treatment.

  2024cites this paper
• Therapeutic Potential of Vasopressin in the Treatment of Neurological Disorders.

  2024cites this paper
• The Impact of VEGF-C-Induced Dural Lymphatic Vessel Growth on Ischemic Stroke Pathology

  2024cites this paper
• The Role of Arginine-Vasopressin in Stroke and the Potential Use of Arginine-Vasopressin Type 1 Receptor Antagonists in Stroke Therapy: A Narrative Review

  2023influential citation
• Heat-Stress Preconditioning Attenuates Behavioral Responses to Psychological Stress: The Role of HSP-70 in Modulating Stress Responses

  2022cites this paper
• Inactivation of mouse transmembrane prolyl 4-hydroxylase increases blood brain barrier permeability and ischemia-induced cerebral neuroinflammation

  2022cites this paper
• C-Terminal Proarginine Vasopressin is Associated with Disease Outcome and Mortality, but not with Delayed Cerebral Ischemia in Critically Ill Patients with an Aneurysmal Subarachnoid Hemorrhage: A Prospective Cohort Study

  2022cites this paper
• An update on the pharmacological management and prevention of cerebral edema: current therapeutic strategies

  2021cites this paper
• Developmental Dysfunction of the Central Nervous System Lymphatics Modulates the Adaptive Neuro-Immune Response in the Perilesional Cortex in a Mouse Model of Traumatic Brain Injury

  2021cites this paper
• An arylthiazyne derivative is a potent inhibitor of lipid peroxidation and ferroptosis providing neuroprotection in vitro and in vivo

  2021cites this paper
• Intracerebral overexpression of miR-669c is protective in mouse ischemic stroke model by targeting MyD88 and inducing alternative microglial/macrophage activation

  2020cites this paper
• Targeting Caveolin-1 and Claudin-5 with AY9944, Improve Blood–Brain Barrier Permeability; Computational Simulation and Experimental Study

  2020cites this paper
• Rodent Models of Vascular Cognitive Impairment

  2020cites this paper
• Prognostic value of copeptin in patients with aneurysmal subarachnoid hemorrhage.

  2019cites this paper
• The CNS lymphatic system modulates the adaptive neuro-immune response in the perilesional cortex after brain trauma

  2019cites this paper
• Peripheral Administration of IL-13 Induces Anti-inflammatory Microglial/Macrophage Responses and Provides Neuroprotection in Ischemic Stroke

  2019cites this paper
• HX600, a synthetic agonist for RXR-Nurr1 heterodimer complex, prevents ischemia-induced neuronal damage.

  2018cites this paper
• Time-Dependent Effects of Arginine-Vasopressin V1 Receptor Inhibition on Secondary Brain Damage after Traumatic Brain Injury

  2017cites this paper
• Copeptin as a biomarker for prediction of prognosis of acute ischemic stroke and transient ischemic attack: a meta-analysis

  2017cites this paper
• The Copper bis(thiosemicarbazone) Complex CuII(atsm) Is Protective Against Cerebral Ischemia Through Modulation of the Inflammatory Milieu

  2017cites this paper
• Sulfosuccinimidyl oleate sodium is neuroprotective and alleviates stroke-induced neuroinflammation

  2017cites this paper
• Pro-nociceptive migraine mediator CGRP provides neuroprotection of sensory, cortical and cerebellar neurons via multi-kinase signaling

  2017cites this paper
• Copeptin and NT-proBNP for prediction of all-cause and cardiovascular death in ischemic stroke

  2017cites this paper
• DHCR24 exerts neuroprotection upon inflammation-induced neuronal death

  2017cites this paper
• Vasopressin Hypersecretion-Associated Brain Edema Formation in Ischemic Stroke: Underlying Mechanisms.

  2016cites this paper
• Conivaptan, a Selective Arginine Vasopressin V1a and V2 Receptor Antagonist Attenuates Global Cerebral Edema Following Experimental Cardiac Arrest via Perivascular Pool of Aquaporin-4

  2016cites this paper
• Arginine Vasopressin and Copeptin in Perinatology

  2016cites this paper
• Bexarotene targets autophagy and is protective against thromboembolic stroke in aged mice with tauopathy

  2016cites this paper
• The Effects of Clinically Relevant Hypertonic Saline and Conivaptan Administration on Ischemic Stroke.

  2016cites this paper
• POLYMORPHISM OF THE SYNDROME OF HYPERACTIVE URINARY BLADDER IN PATIENTS WITH ACUTE AND CHRONIC VASCULAR DISEASES OF THE BRAIN

  2016cites this paper
• Anti‐inflammatory effects of ADAMTS‐4 in a mouse model of ischemic stroke

  2016cites this paper
• Effect of arginine vasopressin on the cortex edema in the ischemic stroke of Mongolian gerbils.

  2015cites this paper
• Prediction of all-cause mortality with copeptin in cardio-cerebrovascular patients: A meta-analysis of prospective studies.

  2015cites this paper
• Prognostic role of copeptin after stroke: A systematic review and meta-analysis of observational studies

  2015cites this paper
• Immunomodulation by interleukin-33 is protective in stroke through modulation of inflammation.

  2015cites this paper
• Plasma levels of copeptin predict 1-year mortality in patients with acute ischemic stroke

  2014cites this paper
• Selective vasopressin-1a receptor antagonist prevents brain edema, reduces astrocytic cell swelling and GFAP, V1aR and AQP4 expression after focal traumatic brain injury.

  2014cites this paper
• The 90-day prognostic value of copeptin in acute intracerebral hemorrhage

  2014cites this paper
• Extract of Antrodia camphorata Exerts Neuroprotection against Embolic Stroke in Rats without Causing the Risk of Hemorrhagic Incidence

  2014cites this paper
• Treatment of stroke related refractory brain edema using mixed vasopressin antagonism: a case report and review of the literature

  2014cites this paper
• Antagonists of the Vasopressin V1 Receptor and of the β1-Adrenoceptor Inhibit Cytotoxic Brain Edema in Stroke by Effects on Astrocytes – but the Mechanisms Differ

  2014cites this paper
• Real-Time Monitoring of Changes in Brain Extracellular Sodium and Potassium Concentrations and Intracranial Pressure after Selective Vasopressin-1a Receptor Inhibition following Focal Traumatic Brain Injury in Rats

  2014influential citation
• Role of vasopressin and its antagonism in stroke related edema

  2014cites this paper
• Western-type diet modulates inflammatory responses and impairs functional outcome following permanent middle cerebral artery occlusion in aged mice expressing the human apolipoprotein E4 allele

  2013cites this paper
• Targeted over-expression of endothelin-1 in astrocytes leads to more severe brain damage and vasospasm after subarachnoid hemorrhage

  2013cites this paper
• Title Targeted over-expression of endothelin-1 in astrocytes leads to more severe brain damage and vasospasm after subarachnoid hemorrhage

  2013cites this paper
• Plasma copeptin and long‐term outcomes in acute ischemic stroke

  2013cites this paper
• Increased Brain Volume Among Good Grade Patients with Intracerebral Hemorrhage. Results from the Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH) Study

  2013cites this paper
• Vascular and Neuronal Ischemic Damage in Cryonics Patients

  2012cites this paper
• Oxytocin and Myometrial Contractility in Labor

  2012cites this paper
• Changes in circulating oxytocin and oxytocin receptor levels in labor

  2012cites this paper
• Vasopressin V1a and V1b receptors: from molecules to physiological systems.

  2012cites this paper
• Hyperthermia worsens ischaemic brain injury through destruction of microvessels in an embolic model in rats

  2012cites this paper
• Therapeutic Effects of a Combinatorial Treatment of Simvastatin and Bone Marrow Stromal Cells on Experimental Embolic Stroke

  2012cites this paper
• The Oxytocin-Oxytocin Receptor System and Its Antagonists as Tocolytic Agents

  2011cites this paper
• Arginine-vasopressin V1a receptor inhibition improves neurologic outcomes following an intracerebral hemorrhagic brain injury.

  2011influential citation
• Brain Edema in Neurological Diseases

  2011cites this paper
• Detection of copeptin in peripheral blood of patients with aneurysmal subarachnoid hemorrhage

  2011cites this paper
• THR-18, a 18-mer peptide derived from PAI-1, is neuroprotective and improves thrombolysis by tPA in rat stroke models

  2011cites this paper
• Agent for the prophylaxis and treatment of age-related diseases and disorders, as well as to extend the life

  2011cites this paper
• A Bolus of Conivaptan Lowers Intracranial Pressure in a Patient with Hyponatremia after Traumatic Brain Injury

  2011cites this paper
• Tropisetron ameliorates ischemic brain injury in an embolic model of stroke.

  2011cites this paper
• Vasopressin Amplifies the Production of Proinflammatory Mediators in Traumatic Brain Injury

  2010influential citation
• p120 catenin/αN‐catenin are molecular targets in the neuroprotection and neuronal plasticity mediated by atorvastatin after focal cerebral ischemia

  2010influential citation
• Emerging concepts in the pathophysiology of traumatic brain injury.

  2010cites this paper
• The Treatment of Traumatic Brain Injury with Velcade

  2010cites this paper
• Arginine-Vasopressin V1 but not V2 Receptor Antagonism Modulates Infarct Volume, Brain Water Content, and Aquaporin-4 Expression Following Experimental Stroke

  2010cites this paper
• Ion and Water Transport across the Blood–Brain Barrier

  2009cites this paper
• Rosiglitazone Alone Or in Combination with Tissue Plasminogen Activator Improves Ischemic Brain Injury in an Embolic Model in Rats

  2009cites this paper
• Effect of vasopressin on survival of Purkinje neurons in rat cerebellar slices after an in vitro simulated ischemia.

  2009cites this paper
• Vasopressin-dependent short-term regulation of aquaporin 4 expressed in Xenopus oocytes.

  2009cites this paper
• Targeted Overexpression of Endothelin-1 in Astrocytes Leads to More Severe Cytotoxic Brain Edema and Higher Mortality

  2009cites this paper
• Cerebral microvascular endothelial cell Na/H exchange: evidence for the presence of NHE1 and NHE2 isoforms and regulation by arginine vasopressin.

  2009cites this paper
• Proliferating Progenitor Cells: A Required Cellular Element for Induction of Ischemic Tolerance in the Brain

  2008cites this paper
• Non-peptide arginine-vasopressin antagonists: the vaptans.

  2008cites this paper
• Reduction of ischemic brain injury in rats with normothermic and hyperthermic conditions.

  2008cites this paper
• Changes and effects of plasma arginine vasopressin in traumatic brain injury

  2008cites this paper
• Tissue oxygenation during management of cerebral perfusion pressure with phenylephrine or vasopressin*

  2008cites this paper
• Vasopressin in vascular regulation and water homeostasis in the brain.

  2008cites this paper
• Modulation of AQP4 expression by the selective V1a receptor antagonist, SR49059, decreases trauma-induced brain edema.

  2008influential citation
• Role of Vasopressin V1a and V2 Receptors for the Development of Secondary Brain Damage after Traumatic Brain Injury in Mice

  2008influential citation
• Ginsenoside Rb1 reduces neurodegeneration in the peri-infarct area of a thromboembolic stroke model in non-human primates.

  2008cites this paper
• THE EFFECT OF ULTRASOUND ON THROMBOEMBOLIC MODEL OF BRAIN STROKE IN RAT

  2007cites this paper
• Cerebral correlates of hyponatremia

  2007cites this paper
• Combination therapy of rosiglitazone, a peroxisome proliferator-activated receptor-gamma ligand, and NMDA receptor antagonist (MK-801) on experimental embolic stroke in rats.

  2007cites this paper
• Critical role of microvasculature basal lamina in ischemic brain injury.

  2007cites this paper
• Vasopressin antagonists

  2006cites this paper
• Physiology and pathophysiology of Na+/H+ exchange and Na+ -K+ -2Cl- cotransport in the heart, brain, and blood.

  2006cites this paper
• ROSIGLITAZONE, A PEROXISOME PROLIFERATOR‐ACTIVATED RECEPTOR‐γ LIGAND, REDUCES INFARCTION VOLUME AND NEUROLOGICAL DEFICITS IN AN EMBOLIC MODEL OF STROKE

  2006cites this paper
• Modulation of the Blood-Brain Barrier During Hypertension Development

  2006cites this paper
• Reactive Astrocytes: Phenotypic and Functional Characteristics and Astrocytes as Neural Stem Cells

  2006cites this paper
• Traumatic brain injury results in a concomitant increase in neocortical expression of vasopressin and its V1a receptor.

  2006cites this paper
• Clot Fragments Formed from Original Thrombus Obstruct Downstream Arteries in the Ischemic Injured Brain

  2006cites this paper
• Neurological impact of vasopressin dysregulation and hyponatremia

  2006cites this paper
• A long-term video-EEG and behavioral follow-up after endothelin-1 induced middle cerebral artery occlusion in rats.

  2006cites this paper
• Vasopressin Antagonism: Potential Impact on Neurologic Disease

  2006cites this paper